4 magnificent FTSE 100 and FTSE 250 value shares to consider!

The London stock market is jam-packed with excellent value shares despite the recent bull run. Here are four I think are worth a very close look.

| More on:
Young Caucasian woman holding up four fingers

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The FTSE 100 and FTSE 250 indices have experienced lift-off in recent weeks. But despite significant share price gains, many top UK shares still look dirt cheap at current levels.

Here are four top bargains for savvy investors to consider.


Concerns over its drugs pipeline leave GSK (LSE:GSK) shares trading at a discount to the broader pharma sector. For 2024, the Footsie firm deals on a price-to-earnings (P/E) ratio of just 11.4 times.

While recent signs here have been more encouraging — in the first quarter, it had 89 products in development, and four positive phase III test results — any setbacks at the lab or with regulators could damage its share price again.

I’d be prepared to give GSK the benefit of the doubt however. Not only do I feel any dangers are baked into the company’s rock-bottom valuation, it’s also important to remember GSK has a brilliant record of getting its product to market. This explains its mighty £75bn market-cap.

Babcock International Group

Defence business Babcock International (LSE:BAB) also looks like a brilliant bargain at current prices.

The FTSE 250 company — which provides engineering and training services to armed forces across the globe — trades on a forward-looking P/E ratio of 13.9 times. By comparison, UK-listed peers BAE Systems and Chemring carry much heavier multiples of 19.9 times and 19.2 times respectively.

Investing in defence shares can be an excellent long-term play. This is because weapons demand remains broadly stable at all points of the economic cycle.

Buying Babcock shares could be an especially good idea today though, as spending soars across the defence sector. That’s even though project delivery problems are a constant danger than could affect future revenues.


A rising gold price has lifted miner Centamin‘s (LSE:CEY) share price through the roof more recently. But a forward P/E ratio of 9.3 times suggests that the company remains a brilliant bargain.

Digging for metals can be unexpectedly expensive. Problems can be commonplace that crush profits and push share prices lower.

But Egypt-focused Centamin has an excellent history on this front. It has produced 5m ounces of yellow metal from its flagship Sukari mine since 2009. The complex has almost 6m ounces of further reserves too, suggesting it could remain a lucrative money spinner for some time to come.


Like those other shares I describe, Aviva (LSE:AV.) trades on an attractive P/E ratio. For 2024, this sits at a modest 11.4 times.

On top of this, the life insurer also trades on a corresponding price-to-earnings growth (PEG) ratio of 0.4. Any reading below 1 indicates that a stock is undervalued. Finally, Aviva shares carry a market-beating 7.1% dividend yield for this year.

This FTSE 100 share has an excellent chance to capitalise on the UK’s rapidly-growing elderly population. This demographic change is set to drive demand for retirement, wealth and insurance products much higher from current levels.

Aviva faces significant competition to grow profits. But the insurer’s long history (it’s been selling products since 1696) suggests it has what it takes to seize this opportunity.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has positions in Aviva Plc. The Motley Fool UK has recommended BAE Systems and GSK. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Photo of a man going through financial problems
Investing Articles

Down 15% in a week! What’s gone wrong with the National Grid share price?

The National Grid share price isn't supposed to crash but now it has. Harvey Jones is wondering whether to take…

Read more »

Group of young friends toasting each other with beers in a pub
Investing Articles

Taylor Wimpey just paid me £158.78. I’m aiming to turn that into a £100k yearly second income

Harvey Jones says small, regular dividend payments can turn a few pounds into a mighty second income, if he gives…

Read more »

A pastel colored growing graph with rising rocket.
Value Shares

These FTSE 250 shares are tipped to rise 14% to 18% in the next year!

Looking for the best FTSE 250 momentum shares to buy? Here are two that City analysts expect to soar in…

Read more »

Young mixed-race woman jumping for joy in a park with confetti falling around her
Investing Articles

Lloyds’ share price is up 20% in 3 months! How high can it go?

Lloyds’ share price has ripped higher recently. Here, Edward Sheldon provides his view on the level it could potentially climb…

Read more »

Investing Articles

Why the Rolls-Royce share price could continue to outperform

The Rolls-Royce share price keeps moving forward, but this Fool thinks it's still behind where it ought to be after…

Read more »

Fireworks display in the shape of willow at Newcastle, Co. Down , Northern Ireland at Halloween.
Investing Articles

The City expects explosive growth in earnings from this almost-penny stock

It’s rare to find earnings predictions as robust as those for this not-quite-a-penny stock, so I’d research and consider it…

Read more »

Investing Articles

As earnings rise 600%, is Nvidia still the best AI stock to buy?

With the supply and demand equation still looking strong for Nvidia, is the stock still the best AI opportunity for…

Read more »

Value Shares

Cheap UK stocks are soaring! Here’s 1 to consider buying now

In recent weeks, many UK stocks have surged. Here, Edward Sheldon highlights a blue-chip FTSE 100 share he believes could…

Read more »